Foxa1 and Foxa2 regulate bile duct development in mice

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Don C. Rockey  Clinical Gastroenterology and Hepatology 
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Mario Strazzabosco, Luca Fabris  Journal of Hepatology 
Volume 51, Issue 3, Pages (September 2009)
Pathological roles of purinergic signaling in the liver
The inflammasome in liver disease
Mario Strazzabosco, Luca Fabris  Journal of Hepatology 
Anatoliy I. Masyuk, Tatyana V. Masyuk, Nicholas F. LaRusso 
Obesity, inflammation, and liver cancer
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
Liver regeneration Journal of Hepatology
Volume 52, Issue 3, Pages (March 2010)
Thoetchai (Bee) Peeraphatdit, Douglas A. Simonetto, Vijay H. Shah 
Volume 57, Issue 1, Pages 6-8 (July 2012)
Don C. Rockey  Clinical Gastroenterology and Hepatology 
Hedgehog signaling in the liver
Agustín Albillos, Margaret Lario, Melchor Álvarez-Mon 
Histamine regulation of biliary proliferation
New class of anti-inflammatory agents for colonic epithelial cells
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Volume 56, Issue 3, Pages (March 2012)
Hepatitis C virus entry and glucocorticosteroids
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Gut–liver immunity Journal of Hepatology
Mechanisms of Hepatic Fibrogenesis
Biology of the immunomodulatory molecule HLA-G in human liver diseases
Volume 66, Issue 2, Pages (February 2017)
Targeting the gut-liver axis in liver disease
Inflammation and portal hypertension – The undiscovered country
Hepatitis C core protein – The “core” of immune deception?
Ning Li, Sergei I. Grivennikov, Michael Karin  Cancer Cell 
Signalling pathways in alcohol-induced liver inflammation
The quest for liver progenitor cells: A practical point of view
Volume 53, Issue 4, Pages (October 2010)
Mechanisms of iron hepatotoxicity
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Why men are at higher risk for hepatocellular carcinoma?
Volume 45, Issue 4, Pages (October 2006)
Autophagy and senescence in fibrosing cholangiopathies
Emina Halilbasic, Thierry Claudel, Michael Trauner 
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Volume 57, Issue 5, Pages (November 2012)
Bin Gao, Hua Wang, Fouad Lafdil, Dechun Feng  Journal of Hepatology 
Targeting STAT3 in hepatocellular carcinoma: Sorafenib again…
Cannabinoid signaling and liver therapeutics
Karel J. van Erpecum, Frank G. Schaap  Journal of Hepatology 
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Notch Signaling in Hepatocellular Carcinoma: Guilty in Association!
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Salvatore Papa, Concetta Bubici  Journal of Hepatology 
Ryan P. Hobbs, Susan H. Smith, Spiro Getsios 
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Macrophage heterogeneity in liver injury and fibrosis
The dynamic biliary epithelia: Molecules, pathways, and disease
Volume 56, Issue 4, Pages (October 1999)
GR Extinguishes Inflamed Chromatin, and NF-κB Evacuates
Volume 65, Issue 4, Pages (October 2016)
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Cytokine Signaling Modules in Inflammatory Responses
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Pathogenesis of cholestatic hepatitis C
The balance between Notch/Wnt signaling regulates progenitor cells’ commitment during liver repair: Mystery solved?  Mario Strazzabosco, Luca Fabris 
The origin of biliary strictures after liver transplantation: Is it the amount of epithelial injury or insufficient regeneration that counts?  Negin Karimian,
EpCAM in hepatocytes and their progenitors
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Molecular and cellular mechanisms of allergic disease
Platelets arrive at the scene of fibrosis……studies
Keeping STATs on Memory CD8+ T Cells
Presentation transcript:

Foxa1 and Foxa2 regulate bile duct development in mice Mario Strazzabosco  Journal of Hepatology  Volume 52, Issue 5, Pages 765-767 (May 2010) DOI: 10.1016/j.jhep.2009.12.022 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Ductular proliferation and the expansion of “reactive cholangiocytes” is a common compensatory and reparative response to liver damage (A). Reactive cholangiocytes, also called “liver progenitor cells” because of their ability to differentiate into hepatocytes, are thought to originate from epithelial cells lining cholangioles and ducts of Hering. Reactive cholangiocytes generate a number of growth factors, chemokines, and cytokines generating a network of autocrine and paracrine signals that play a key role in liver repair and cross talk with the other cell types of the hepatic reparative complex (mesenchymal cells, inflammatory cells, endothelial cells) (B). The molecular mechanisms regulating the activation of reactive cholangiocytes are not known. The paper from Li et al. begins to shed light on these mechanisms showing that release of Foxa1/2 repression is essential to allow transcription of IL-6 in developing and reactive biliary cells. Foxa1/2 are “pioneer” factors, able to open the chromatin and enhance the binding of other transcription factors, such as the glucocorticoid receptor (GR), to their target genes. The IL-6 promoter contains closely spaced binding sites for Foxa1/2, GR, and NF-κB. GR suppresses the IL-6 promoter. Li et al. showed that Foxa1/2 are required to enable the GR to bind to the interlukin-6 (IL-6) promoter. In their absence, NF-κB, will bind to the IL-6 promoter instead of GR, resulting in stimulation of IL-6 production. It is tempting to speculate that similar models may apply to several of the other paracrine and autocrine factors generated by reactive cells (C). Journal of Hepatology 2010 52, 765-767DOI: (10.1016/j.jhep.2009.12.022) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions